Key Events This Week
18 May: Stock opens at Rs.124.40, declines 4.16%
19 May: Sharp rebound of 7.15% post Q4 FY26 results announcement
20 May: Stock retreats 5.25% amid margin pressure concerns
22 May: Week closes at Rs.129.05, down 0.58% for the week
Are Amanta Healthcare Ltd latest results good or bad?
2026-05-20 19:26:00Amanta Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹76.99 crores, marking a sequential increase of 3.36% from the previous quarter and a year-on-year growth of 6.84%. This indicates some positive momentum in revenue generation, potentially suggesting improved market penetration or product portfolio expansion. However, the operational efficiency metrics reveal challenges. The net profit for the quarter rose to ₹5.53 crores, a 19.44% increase from Q3 FY26, driven by lower interest costs and a slight uptick in other income. Despite this, the net profit remains below the previous year's figure, highlighting ongoing profitability concerns. The operating margin contracted to 19.42%, down from 20.62% in the prior quarter, indicating significant cost pressures or pricing challenges that may affect the company's ability to maintain...
Read full news article
Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure
2026-05-20 08:00:24Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record net sales and a strong operating profit to interest ratio, the company’s operating profit margin contracted significantly, prompting a downgrade in its Mojo Grade from Hold to Sell.
Read full news article
Amanta Healthcare Q4 FY26: Margin Pressures Overshadow Revenue Growth
2026-05-19 22:17:47Amanta Healthcare Limited, a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹493.00 crores, reported a mixed performance for Q4 FY26 (January-March 2026), with net profit rising to ₹5.53 crores from ₹4.63 crores in the previous quarter, marking a sequential growth of 19.44%. However, the quarter revealed concerning margin compression, with operating profit margins declining to 19.42% from 20.62% in Q3 FY26, whilst the stock surged 7.15% to ₹133.30 following the results announcement.
Read full news article
Amanta Healthcare Ltd is Rated Hold
2026-05-17 10:10:27Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.
Read full news articleWhen is the next results date for Amanta Healthcare Ltd?
2026-05-12 23:18:01The next results date for Amanta Healthcare Ltd is scheduled for 19 May 2026....
Read full news articleAmanta Healthcare Ltd Falls 1.85%: 3 Key Factors Driving the Weekly Decline
2026-05-09 09:01:57
Key Events This Week
May 4: Technical momentum shifts amid mixed market signals
May 5: Technical momentum shifts to mildly bullish with strong price gains
May 6: MarketsMOJO upgrades rating to Hold following financial improvements
May 8: Week closes at Rs.137.70, down 1.85%

Amanta Healthcare Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements
2026-05-06 08:38:49Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 5 May 2026, is driven by a combination of enhanced technical trends, robust quarterly financial results, attractive valuation metrics, and increased institutional participation, despite some lingering concerns over long-term fundamentals and debt servicing capacity.
Read full news articleIntimation For Commissioning Of Solar Power Plant For Captive Consumption
30-May-2026 | Source : BSEIntimation for commissioning of solar power plant for captive consumption
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the Financial Year ended on March 31 2026
Statement Of Deviation Or Variation In Utilization Of Funds If Any.
29-May-2026 | Source : BSEstatement of deviation or variation of funds if any
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







